156 related articles for article (PubMed ID: 16484516)
1. Cancer-treatment-induced bone loss, part 1.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
[TBL] [Abstract][Full Text] [Related]
2. Cancer-treatment-induced bone loss, part 2.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
[TBL] [Abstract][Full Text] [Related]
3. Cancer treatment-induced bone loss in patients with breast or prostate cancer.
Maxwell C; Viale PH
Oncol Nurs Forum; 2005 May; 32(3):589-603. PubMed ID: 15897934
[TBL] [Abstract][Full Text] [Related]
4. [ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].
Takahashi S
Clin Calcium; 2011 Aug; 21(8):1239-47. PubMed ID: 21814031
[TBL] [Abstract][Full Text] [Related]
5. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
6. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for the management of cancer treatment induced bone loss.
Bertoldo F; Pancheri S; Zenari S; Boldini S
Expert Opin Emerg Drugs; 2010 Jun; 15(2):323-42. PubMed ID: 20377485
[TBL] [Abstract][Full Text] [Related]
8. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.
D'Oronzo S; Stucci S; Tucci M; Silvestris F
Cancer Treat Rev; 2015 Nov; 41(9):798-808. PubMed ID: 26410578
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
10. [Prostate cancer and Cancer Treatment-Induced Bone Loss(CTIBL)].
Matsushima H
Clin Calcium; 2016 Jul; 26(7):1039-45. PubMed ID: 27346316
[TBL] [Abstract][Full Text] [Related]
11. Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.
Body JJ; Bergmann P; Boonen S; Boutsen Y; Devogelaer JP; Goemaere S; Reginster JY; Rozenberg S; Kaufman JM
Osteoporos Int; 2007 Nov; 18(11):1439-50. PubMed ID: 17690930
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
13. Bone loss and fracture risk associated with cancer therapy.
Guise TA
Oncologist; 2006; 11(10):1121-31. PubMed ID: 17110632
[TBL] [Abstract][Full Text] [Related]
14. Some musculo-skeletal sequelae in cancer survivors.
Aksnes LH; Bruland ØS
Acta Oncol; 2007; 46(4):490-6. PubMed ID: 17497316
[TBL] [Abstract][Full Text] [Related]
15. [Cancer Treatment-Induced Bone Loss(CTIBL)].
Fukumoto S; Matsumoto T
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1685-1689. PubMed ID: 30587719
[TBL] [Abstract][Full Text] [Related]
16. Skeletal health in breast cancer survivors.
Bruyère O; Bergmann P; Cavalier E; Gielen E; Goemaere S; Kaufman JM; Rozenberg S; Body JJ
Maturitas; 2017 Nov; 105():78-82. PubMed ID: 28838807
[TBL] [Abstract][Full Text] [Related]
17. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
18. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
[TBL] [Abstract][Full Text] [Related]
19. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
Garg A; Leitzel K; Ali S; Lipton A
Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid for cancer therapy--induced and postmenopausal bone loss.
Brufsky AM
Expert Opin Pharmacother; 2008 Apr; 9(6):1013-28. PubMed ID: 18377343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
